
Cellvizio® is the real-time in vivo cellular imaging platform that significantly improves the classification and risk-stratification of indeterminate cysts quickly and with greater certainty.
This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients – making a transformative change in medicine.
Click here for more information on the value of using Cellvizio in Pancreatic Cystic Lesions (PCLs).
Latest Updates on nCLE in Pancreatic Cysts:
Mauna Kea Technologies Inc.
Contact Us
✉️ communications@maunakeatech.com
24 Denby Road, Unit 140,
Allston, MA 02134
Toll free : +1 (888) 590-1798
Tel : +1 (617) 657-1550
Fax : +1 (888) 797-6640